Proteome Sciences plc (LON:PRM – Get Free Report) shares rose 22.8% during mid-day trading on Friday . The company traded as high as GBX 4.20 ($0.05) and last traded at GBX 4.20 ($0.05). Approximately 338,224 shares were traded during trading, an increase of 83% from the average daily volume of 185,236 shares. The stock had previously closed at GBX 3.42 ($0.04).
Proteome Sciences Stock Up 40.4 %
The business has a 50-day moving average of GBX 2.97 and a 200-day moving average of GBX 3.12. The stock has a market cap of £14.17 million, a price-to-earnings ratio of -480.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- How Can Investors Benefit From After-Hours Trading
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- P/E Ratio Calculation: How to Assess Stocks
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
